Notes payable, plus accrued interest, totaled approximately $6.9 million. The current portion of the notes payable plus ...

Air pollution is a key environmental risk factor for autism, influencing neurodevelopment through neuroinflammation, ...

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic ...

Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye"), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health ...

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways ...

We have a fundamental problem with how our bodies make energy from food – so says Stanford-trained physician, Dr Casey Means, ...

According to the nutritionist, disruptions in our gut microbiome can significantly impact our weight management efforts ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Infosys Science Foundation announces Infosys Prize 2024 winners in six categories, awarding $100,000 prize purse to ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.